Skip to main content

Table 2 Clinical data of infants carrying the m.1555A>G-genotype

From: Mitochondrial mutation m.1555A>G as a risk factor for failed newborn hearing screening in a large cohort of preterm infants

Number

Birth weight category [grams]

Gestational age [weeks]

Gender [m/f]

Mutliple [y/n]

Gentamicin treatment [y/n]

Result of hearing screening

1

1100-1199

28

M

Y

Y

Pass

2

1100-1199

28

M

Y

Y

Pass

3

800-899

25

F

N

Y

Pass

4

1200-1299

29

M

N

N

Pass

5

1200-1299

32

F

N

N

Pass

6

1200-1299

29

F

Y

Y

Pass

7

800-899

29

F

Y

Y

Fail

8

1400-1499

32

M

N

Y

Pass

9

1300-1399

30

M

N

Y

Pass

10

1400-1499

30

F

Y

Y

Pass

11

1300-1399

30

F

Y

Y

Fail

12

<400

24

M

N

Y

Fail

  1. Birth weight and gestational age are given as completed 100 grams/completed weeks, respectively. All aminoglycoside treated infants received gentamicin. Patients 1 and 2, 6 and 7 and patients 10 and 11 were twin pairs. None of the patients was treated with furosemide.